Finn Waagstein

Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Immunoadsorption in dilated cardiomyopathy: the IASO-DCM trial.

Immunoadsorption in dilated cardiomyopathy: the IASO-DCM trial.

Journal: European heart journal

Published: September 07, 2025

Multicentre, randomized, double-blind, prospective study on the effects of ImmunoAdSorptiOn on cardiac function in patients with Dilated CardioMyopathy (IASO-DCM): Rationale and design.

Multicentre, randomized, double-blind, prospective study on the effects of ImmunoAdSorptiOn on cardiac function in patients with Dilated CardioMyopathy (IASO-DCM): Rationale and design.

Journal: European journal of heart failure

Published: April 24, 2024

Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.

Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.

Journal: Journal of the American College of Cardiology

Published: April 07, 2019

The β-blocker uptitration in elderly with heart failure regarding biomarker levels: CIBIS-ELD substudy.

The β-blocker uptitration in elderly with heart failure regarding biomarker levels: CIBIS-ELD substudy.

Journal: Biomarkers in medicine

Published: November 20, 2018

Digoxin use and lower risk of 30-day all-cause readmission in older patients with heart failure and reduced ejection fraction receiving β-blockers.

Digoxin use and lower risk of 30-day all-cause readmission in older patients with heart failure and reduced ejection fraction receiving β-blockers.

Journal: Clinical cardiology

Published: November 18, 2017

The Evolution of the Use of β-Blockers to Treat Heart Failure: A Conversation With Finn Waagstein, MD.

The Evolution of the Use of β-Blockers to Treat Heart Failure: A Conversation With Finn Waagstein, MD.

Journal: Circulation

Published: September 07, 2017

Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-β treatment in patients with chronic viral cardiomyopathy.

Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-β treatment in patients with chronic viral cardiomyopathy.

Journal: Clinical research in cardiology : official journal of the German Cardiac Society

Published: October 28, 2015

Improvement of Ventricular-Arterial Coupling in Elderly Patients with Heart Failure After Beta Blocker Therapy: Results from the CIBIS-ELD Trial.

Improvement of Ventricular-Arterial Coupling in Elderly Patients with Heart Failure After Beta Blocker Therapy: Results from the CIBIS-ELD Trial.

Journal: Cardiovascular drugs and therapy

Published: May 13, 2015

Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction.

Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction.

Journal: European journal of heart failure

Published: March 04, 2015

Beta-blocker Use and 30-day All-cause Readmission in Medicare Beneficiaries with Systolic Heart Failure.

Beta-blocker Use and 30-day All-cause Readmission in Medicare Beneficiaries with Systolic Heart Failure.

Journal: The American journal of medicine

Published: May 07, 2014

An investigation of CYP2D6 genotype and response to metoprolol CR/XL during dose titration in patients with heart failure: a MERIT-HF substudy.

An investigation of CYP2D6 genotype and response to metoprolol CR/XL during dose titration in patients with heart failure: a MERIT-HF substudy.

Journal: Clinical pharmacology and therapeutics

Published: July 16, 2013

Regional differences among female patients with heart failure from the Cardiac Insufficiency BIsoprolol Study in ELDerly (CIBIS-ELD).

Regional differences among female patients with heart failure from the Cardiac Insufficiency BIsoprolol Study in ELDerly (CIBIS-ELD).

Journal: Cardiology journal

Published: May 11, 2013

Showing 1-12 of 14

Last Updated: 09/26/2026